低强度视网膜超声波刺激对快速和非快速眼动睡眠的调节效应
Teng Wang1,2, Mengran Wang1,2, Jiawei Wang3
1School of Electrical Engineering, Yanshan University, Qinhuangdao 066004, China.
Cerebral cortex (New York, N.Y. : 1991)
|April 11, 2024
概括
视网膜超声波刺激调节小鼠在睡眠期间的神经活动. 然而,这种刺激并没有改善健康或阿尔茨海默氏症患者的睡眠质量.
科学领域:
- 神经科学是一个神经科学.
- 睡眠科学 睡眠科学
- 生物医学工程 生物医学工程
背景情况:
- 神经活动操纵可以影响睡眠阶段.
- 视网膜超声波刺激调节神经活动.
- 它对睡眠阶段和质量的具体影响尚未完全理解.
研究的目的:
- 研究视网膜超声波刺激对睡眠结构和神经活动的影响.
- 为了确定视网膜超声波刺激是否可以提高健康和阿尔茨海默病模型的睡眠质量.
主要方法:
- 在健康和阿尔茨海默病小鼠中利用低强度视网膜超声波刺激.
- 分析了脑电图 (EEG) 数据,以评估睡眠阶段 (REM和NREM).
- 在EEG功率光谱和神经合强度的量化变化.
主要成果:
- 在健康小鼠中,刺激减少了总睡眠时间和NREM睡眠比率,改变了三角波段活动,并在REM睡眠期间改变了甲基波段活动和甲基-马合.
- 在阿尔茨海默氏症小鼠中,刺激减少了总睡眠时间,在REM睡眠期间改变了马波段活动,并修改了三角马和马快速马合.
- 视网膜超声波刺激调节神经活动,但在任何一组都没有改善整体睡眠质量.
结论:
- 视网膜超声波刺激可以调节与REM和NREM睡眠相关的神经活动.
- 这种刺激策略对改善健康或阿尔茨海默病小鼠模型的睡眠质量没有好处.
- 需要进一步的研究来探索用于改善睡眠的替代神经调节技术.
相关概念视频
Sleep-Wake Cycles
1.3K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.3K
Stages of Sleep
188
Sleep progresses through distinct stages, each characterized by specific brain wave patterns and physiological responses ranging from wakefulness to stages of non-rapid eye movement, known as non-REM, to rapid eye movement, referred to as REM. Understanding these stages helps in recognizing how sleep supports various bodily and cognitive functions.
Before sleep begins, in wakefulness, the brain exhibits primarily beta waves, which are high in frequency and low in amplitude, indicating alertness...
Before sleep begins, in wakefulness, the brain exhibits primarily beta waves, which are high in frequency and low in amplitude, indicating alertness...
188
Sedatives and Hypnotics Drugs: Miscellaneous Agents
171
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
171
REM Sleep Behavior Disorder
182
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
182
Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244


